ASPIRE is a loyalty program for consumers and aesthetic providers who use Galderma aesthetic injectable treatments, such as Dysport (abobotulinumtoxinA), the Restylane family of fillers and Sculptra Aesthetic.
To celebrate 1 million loyalists in less than 3.5 years, Galderma will announce the winner of a consumer sweepstakes for ASPIRE members this month.
"As a company invested in growing the aesthetics market, we are thrilled to have a patient loyalty program with such an extensive reach in a short time," says Alisa Lask, General Manager & Vice President of the U.S. Aesthetic Business at Galderma, in a news release. "Galderma plans to continue investing in the program by adding tools and resources to bring enhanced promotions, sharable social media content, and the ability for healthcare providers to leverage powerful big data analytics to drive growth in their practice."